levamisole has been researched along with enalapril in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chongchate, N; Pattaragarn, A; Sumboonnanonda, A; Suntornpoch, V; Supavekin, S | 1 |
3 other study(ies) available for levamisole and enalapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Difficult-to-treat nephrotic syndrome: management and outcome.
Topics: Adjuvants, Immunologic; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Enalapril; Female; Humans; Immunosuppressive Agents; Levamisole; Male; Nephrotic Syndrome; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |